Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy

International Urology and Nephrology

Volumn 45, Issue 1, 2013, Pages 121-127

  Oh, Jong Jin ^a   Hong, Sung Kyu ^b   Lee, Sangchul ^b   Sohn, Seung June ^b   Lee, Sang Eun ^b  

^a CHA University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Diabetes mellitus; Prostate; Prostatectomy; Prostatespecific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GLEASON SCORE; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN DOUBLING TIME; PROSTATECTOMY; RECURRENCE FREE SURVIVAL; SEMINAL VESICLE; TREATMENT OUTCOME;

AGED; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEMINAL VESICLES;

EID: 84873414482     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0306-x     Document Type: Article

References (27)

1. Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071-10782
2. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(11):2056-2062
3. Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Mehrsai AR, Pourmand G (2009) The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate 69(16):1744-1750
4. Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124(6):1398-1403
5. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR (2005) History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control 16(7):789-797
6. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15(10):1977-1983
7. Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL 3rd, Andriole GL (2008) Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 19(10):1267-1276
8. Patel T, Hruby G, Badani K, Abate-Shen C, McKiernan JM (2010) Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin. Urology 76(5):1240-1244
9. Jayachandran J, Aronson WJ, Terris MK, Presti JC Jr., Amling CL, Kane CJ, Freedland SJ (2010) Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev 19(1):9-17
10. D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH (2003) Surrogate end point for prostate cancerspecific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 95(18):1376-1383
11. Valicenti RK, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM (2006) Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02. Int J Radiat Oncol Biol Phys 66(4):1064-1071
12. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294(4):433-439
13. Teeter AE, Banez LL, Presti JC Jr., Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ (2008) What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy A report from the SEARCH database group. J Urol 180(5):1980-1984 discussion 1985
14. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363(9403):157-163
15. Abdollah F, Briganti A, Suardi N, Gallina A, Capitanio U, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F (2011) Does diabetes mellitus increase the risk of highgrade prostate cancer in patients undergoing radical prostatectomy Prostate Cancer Prostatic Dis 14(1):74-78
16. Snyder CF, Stein KB, Barone BB, Peairs KS, Yeh HC, Derr RL, Wolff AC, Carducci MA, Brancati FL (2010) Does preexisting diabetes affect prostate cancer prognosis A systematic review. Prostate Cancer Prostatic Dis 13(1):58-64
17. Lee SE, Lee WK, Jeong MS, Abdullajanov M, Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G, Hong SK (2011) Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men BJU Int 107(8):1250-1255
18. Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E (2008) Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 19(7):703-710
19. Henderson KD, Goran MI, Kolonel LN, Henderson BE, Le Marchand L (2006) Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15(11):2298-2302
20. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21(3):433-440
21. Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26(4):1047-1051
22. Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2003) Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 157(12):1092-1100
23. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160-1167
24. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, Brancati FL, Wolff AC (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and metaanalysis. J Clin Oncol 29(1):40-46
25. Hong SK, Oh JJ, Byun SS, Hwang SI, Lee HJ, Choe G, Lee SE (2012) Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (C = 12)-core prostate biopsy. Prostate 72(1):51-57
26. Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY, Choe G, Lee SE (2009) Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 69(8):820-826
27. Kim HS, Presti JC Jr., Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ (2010) Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate 70(14):1540-1546